Clinical Trial Detail

NCT ID NCT03089606
Title Pembrolizumab TX-naive Distant Mets Melanoma and Use of AMT (PET) at Baseline as Imaging Biomarker
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

melanoma

skin melanoma

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.